author-photo

W. Feng

Novartis

12

Papers

1181

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

1LBA Everolimus plus exemestane for hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2–) advanced breast cancer (BC): overall survival results from BOLERO-2

2014 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (16)
Everolimus plus exemestane for hormone-receptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer: overall survival results from BOLERO-2

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (354)
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (101)
PO59 EFFICACY AND SAFETY OF EVEROLIMUS PLUS EXEMESTANE COMBINATION THERAPY VERSUS MONOTHERAPY WITH EVEROLIMUS OR CAPECITABINE IN HR+, HER2− BREAST CANCER: A MULTI-CENTER, OPEN-LABEL, PHASE 2 TRIAL BOLERO-6

2013 The Breast
Show All
- Source
- Cite
- Save
Citations (2)
Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis

2013 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (342)
Abstract 1288: A Phase I evaluation of safety, pharmacokinetics (PK) and pharmacodynamics (PD) of LDE225, a smoothened (Smo) antagonist, in patients with advanced solid tumors

2011 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Medical costs associated with imatinib (IM) non-compliance in chronic myeloid leukemia (CML) patients (pts)

2007 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
The impact of non-compliance with imatinib (IM) therapy on health care costs

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Compliance and persistency with imatinib

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (21)